Of 13 guidance figures from Cigna Group's earnings releases that Stock Atlas has scored against the reported result, 9 came in above the guide, 0 in range and 4 below. It met or beat its own guidance 69% of the time.
| Period | Measure | Guided | Reported | Result |
|---|---|---|---|---|
| FY2025 | Capital Expenditures | $1.40B | $1.21B | below |
| FY2025 | Revenue | $252.00B | $274.90B | above |
| FY2024 | Cash Flow From Operations Guidance | $11.00B | $10.36B | below |
| FY2024 | Capital Expenditures | $1.50B | $1.41B | below |
| FY2024 | adjusted revenues | $235.00B | $247.12B | above |
| FY2023 | Cash Flow From Operations Guidance | $10.50B | $11.81B | above |
| FY2023 | Revenue | $187.00B | $195.26B | above |
| FY2022 | Cash Flow From Operations Guidance | $8.50B | $8.66B | above |
Above means the reported figure beat the top of the range, in range that it landed inside it or on a point guide, below that it missed. Every guide and revision, and screens across companies, are in the research platform.
Do companies beat their own guidance? The study · Back to Cigna Group financials
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “Cigna Group (CI) guidance record”, stockatlas.com/companies/CI/guidance/, data as of 3 November 2026. Links to this page are welcome.
